Loading...
Testosterone Therapy for the Treatment of Age-Related Hypogonadism: Risks with Uncertain Benefits
Testosterone replacement therapy has been approved in the United States since the 1950s for men with “classical” hypogonadism. These men have specific and well-recognized hypothalamic, pituitary, or testicular conditions leading to deficient or absent endogenous testosterone. A more controversial tr...
Na minha lista:
| Udgivet i: | Androg Clin Res Ther |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Mary Ann Liebert, Inc., publishers
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8142681/ https://ncbi.nlm.nih.gov/pubmed/34041509 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/andro.2020.0018 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|